|
EXP000201
|
NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
|
2020 |
p5RHH
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP000202
|
Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κ…
|
2020 |
CH2R4H2C
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000203
|
Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κ…
|
2020 |
CH2R4H2C
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000204
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
Arg8
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000205
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
TAT
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000206
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
LMWP
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000207
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
STR-Arg8
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000208
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
p5RHH
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000209
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
RALA
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000210
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
Pep-1
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000211
|
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
|
2022 |
Penetratin
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000212
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
PF14
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000213
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF55
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000214
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF71
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000215
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF430
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000216
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF424
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000217
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF436
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000218
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF55
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP000219
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF430
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP000220
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF424
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP000221
|
The Development of Cell-Penetrating Peptides for Efficient and Selective In Viv…
|
2023 |
NF436
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP000222
|
Lipid- and Histidine-Modified Cell-Penetrating Peptides for siRNA Delivery
|
2020 |
S413-PV
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000223
|
Lipid- and Histidine-Modified Cell-Penetrating Peptides for siRNA Delivery
|
2020 |
C12-S413-PV
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000224
|
Lipid- and Histidine-Modified Cell-Penetrating Peptides for siRNA Delivery
|
2020 |
H5-S413-PV
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000225
|
Lipid- and Histidine-Modified Cell-Penetrating Peptides for siRNA Delivery
|
2020 |
C12-H5-S413-PV
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000226
|
Lipid- and Histidine-Modified Cell-Penetrating Peptides for siRNA Delivery
|
2020 |
H5-S413-PV-C12
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000227
|
Self-Assembling Lipid–Peptide Hybrid Nanoparticles of Phospholipid–Nonaarginine…
|
2017 |
Nonaarginine (9R) + Tat
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000228
|
Self-Assembling Lipid–Peptide Hybrid Nanoparticles of Phospholipid–Nonaarginine…
|
2017 |
Nonaarginine (9R) + Tat
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP000229
|
Six-cell penetrating peptide-based fusion proteins for siRNA delivery
|
2015 |
Tat-Tat-dsRBD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000230
|
Six-cell penetrating peptide-based fusion proteins for siRNA delivery
|
2015 |
Tat-Tat-Tat-dsRBD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000231
|
Six-cell penetrating peptide-based fusion proteins for siRNA delivery
|
2015 |
PTD4-PTD4-RNaseIII
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000232
|
Six-cell penetrating peptide-based fusion proteins for siRNA delivery
|
2015 |
PTD4-PTD4-MPG-MPG
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000233
|
Six-cell penetrating peptide-based fusion proteins for siRNA delivery
|
2015 |
Hph1-Hph1-Dicer
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000234
|
Six-cell penetrating peptide-based fusion proteins for siRNA delivery
|
2015 |
Hph1-Hph1-RNaseIII
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000235
|
Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Dis…
|
2016 |
PPABLG
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000236
|
Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Dis…
|
2016 |
PPABLG
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP000237
|
T7-Functionalized Cationic Peptide as a Nanovehicle for Co-delivering Paclitaxe…
|
2021 |
T7-PEG-SHRss
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000238
|
T7-Functionalized Cationic Peptide as a Nanovehicle for Co-delivering Paclitaxe…
|
2021 |
T7-PEG-SHRss
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000239
|
Targeted Polymeric Micelles for siRNA Treatment of Experimental Cancer by Intra…
|
2012 |
cRGD (cyclo-Arg-Gly-Asp)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000240
|
Targeted Polymeric Micelles for siRNA Treatment of Experimental Cancer by Intra…
|
2012 |
cRGD (cyclo-Arg-Gly-Asp)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000241
|
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
|
2007 |
Penetratin
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000242
|
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
|
2007 |
bPrPp (1–30)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000243
|
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
|
2007 |
MPG-NLS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000244
|
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
|
2007 |
TP10
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000245
|
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
|
2007 |
EB1
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000246
|
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
|
2007 |
HA2-penetratin
|
siRNA
|
yes |
no |
yes |
no |
no |
|
EXP000247
|
Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes wi…
|
2012 |
PepFect14 (PF14)
|
splice-correcting oligonucleotide (SCO)
|
yes |
yes |
yes |
no |
no |
|
EXP000248
|
Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery
|
2016 |
STR-KV
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000249
|
Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-tran…
|
2024 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000250
|
Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-tran…
|
2024 |
Nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000251
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
HA2
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000252
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
GALA
|
ASO (PMO)
|
yes |
no |
|
no |
no |
|
EXP000253
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
NLS
|
ASO (PMO)
|
yes |
no |
|
no |
no |
|
EXP000254
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000255
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
HA2-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000256
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
GALA-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000257
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
NLS-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000258
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
H4-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000259
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
A4-ApoE(141–150)
|
ASO (PMO)
|
yes |
no |
|
no |
no |
|
EXP000260
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Myr-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000261
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Myr-HA2-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000262
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000263
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
HA2-ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000264
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Myr-ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000265
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Myr-HA2-ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000266
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
CLIP6
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000267
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
pVEC
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000268
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Cy5-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000269
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Cy5-HA2-ApoE(141–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000270
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Cy5-ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000271
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
Cy5-HA2-ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
no |
no |
|
EXP000272
|
Endosomal escape cell-penetrating peptides significantly enhance pharmacologica…
|
2021 |
HA2-ApoE(133–150)
|
ASO (PMO)
|
yes |
yes |
|
yes |
yes |
|
EXP000273
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
PFV
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000274
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
P4
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000275
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
SP
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP000276
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
AA3H
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000277
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
TLM
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000278
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
Pept1
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000279
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
C105Y
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000280
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
TP10
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000281
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
M918
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000282
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
MPG
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000283
|
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense…
|
2025 |
R9
|
ASO
|
yes |
no |
|
no |
no |
|
EXP000284
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
PepFect14
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000285
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-WT
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000286
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-Orn
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000287
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-His
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000288
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-His&Orn
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000289
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-v1
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP000290
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-v2
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000291
|
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Pe…
|
2023 |
hLF-v3
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP000292
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000293
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 2
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000294
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 3
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000295
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 4
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000296
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000297
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 6
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000298
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Peptide 7
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000299
|
Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular De…
|
2019 |
Cyc R9
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000300
|
Enhanced small interfering RNA delivery into cells by exploiting the additive e…
|
2015 |
N-L
|
siRNA
|
yes |
no |
|
no |
no |